Sclerotherapy treatment of aneurysmal bone cysts
Session
Medicine and Nursing
Description
Aneurysmal bone cysts (ABCs) are benign bone lesions arising predominantly in the pediatric population that can cause local pain, swelling, and pathologic fracture. Primary lesions, which constitute roughly two thirds of all ABCs, are thought to be neoplastic in nature, with one third of ABCs arising secondary to other tumors. Diagnosis is made with various imaging modalities, which exhibit characteristic features such as “fluid-fluid levels,” although biopsy is critical, as telangiectatic osteosarcoma cannot be excluded based on imaging alone. Currently, the standard of care and most widely employed treatment is intralesional curettage. However, tumor recurrence with curettage alone is common and has driven some to propose a multitude of adjuvants with varying efficacy and risk profiles. Historically, therapies such as en bloc resection or radiation therapy were utilized as an alternative to decrease the recurrence rate, but these therapies imposed high morbidity. As a result, modern radiological techniques now seek to simultaneously reduce morbidity and recurrence. One such method is sclerotherapy of ABC with Aetosclerol 3% in several cycles that in our cases (4 patients) the effect was extremely good. The sclerotherapy was performed under CT guidance and local anaesthesia.
Keywords:
Aneurysmal bone cyst, Pediatric tumor, Benign bone tumor, sclerotherapy
Proceedings Editor
Edmond Hajrizi
ISBN
978-9951-550-47-5
Location
UBT Kampus, Lipjan
Start Date
30-10-2021 12:00 AM
End Date
30-10-2021 12:00 AM
DOI
10.33107/ubt-ic.2021.217
Recommended Citation
Kutllovci, Arben; Ahmetgjekaj, Ilir; and Gjonbalaj, Naser, "Sclerotherapy treatment of aneurysmal bone cysts" (2021). UBT International Conference. 195.
https://knowledgecenter.ubt-uni.net/conference/2021UBTIC/all-events/195
Sclerotherapy treatment of aneurysmal bone cysts
UBT Kampus, Lipjan
Aneurysmal bone cysts (ABCs) are benign bone lesions arising predominantly in the pediatric population that can cause local pain, swelling, and pathologic fracture. Primary lesions, which constitute roughly two thirds of all ABCs, are thought to be neoplastic in nature, with one third of ABCs arising secondary to other tumors. Diagnosis is made with various imaging modalities, which exhibit characteristic features such as “fluid-fluid levels,” although biopsy is critical, as telangiectatic osteosarcoma cannot be excluded based on imaging alone. Currently, the standard of care and most widely employed treatment is intralesional curettage. However, tumor recurrence with curettage alone is common and has driven some to propose a multitude of adjuvants with varying efficacy and risk profiles. Historically, therapies such as en bloc resection or radiation therapy were utilized as an alternative to decrease the recurrence rate, but these therapies imposed high morbidity. As a result, modern radiological techniques now seek to simultaneously reduce morbidity and recurrence. One such method is sclerotherapy of ABC with Aetosclerol 3% in several cycles that in our cases (4 patients) the effect was extremely good. The sclerotherapy was performed under CT guidance and local anaesthesia.